Colorectal Cancer Actionable Panel

Test Code
SLS162600

What is the Colorectal Cancer Actionable Panel?

This test analyzes 7 key colorectal cancer genes along with Microsatellite Instability (MSI) status using PCR-based analysis. MSI is an important marker for immunotherapy eligibility and prognosis.

Genes Covered/ No. of Genes: 7 Genes, MSI by PCR

Who Is This Test For?

Colorectal cancer patients being considered for immunotherapy

Key Features

  • Evaluates 7 clinically relevant genes associated with colorectal cancer
  • Detects Microsatellite Instability (MSI) using PCR methodology

Clinical Applications

  • Identifies MSI-High (MSI-H) tumors, which are likely to respond to immune checkpoint inhibitors
  • Enables personalized therapy selection

Colorectal Cancer

Contact Us